BHVN
Biohaven Ltd.
There isn't enough reported data to score BHVN yet.
BHVN Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| Unavailable | |
| Unavailable |
BHVN's revenue and profitability are currently weak. There isn't enough data to rate its cash flow and balance sheet.
BHVN PE Valuation
BHVN has no meaningful PE right now: it lost money over the past year.
BHVN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect BHVN's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
BHVN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.76 | +$3.73 |
| Q2 2026 | -$4.54 | +$3.01 |
| Q1 2026 | -$5.57 | +$3.68 |
| Q4 2025 | -$6.86 | +$2.42 |
| Q3 2025 | -$7.49 | +$1.93 |
| Q2 2025 | -$7.55 | +$1.67 |
| Q1 2025 | -$9.25 | -$2.35 |
| Q4 2024 | -$9.28 | -$3.55 |
BHVN is still losing money, but far less than before: $3.76 per share over the past year, against $15.26 at its worst in mid-2021.
BHVN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2021 | $92.9M | +858% |
| Q1 2021 | $43.8M | +3707% |
BHVN's revenue has slid since its 2021 peak: $0 last quarter, down 100% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2021 | -185% | +1471 points |
| Q1 2021 | -538% | +12576 points |
| Q4 2020 | -486% | N/A |
| Q3 2020 | -924% | N/A |
| Q2 2020 | -1656% | N/A |
| Q1 2020 | -13114% | N/A |
BHVN's operating margin was −185% last quarter, up 1471 points from the same quarter a year ago.
BHVN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$107M | +$38.7M |
| Q2 2026 | -$85.6M | +$82.6M |
| Q1 2026 | -$149.9M | +$15.7M |
| Q4 2025 | -$130.7M | +$40.1M |
| Q3 2025 | -$145.7M | -$3.8M |
| Q2 2025 | -$168.2M | +$2.6M |
| Q1 2025 | -$165.6M | -$62.5M |
| Q4 2024 | -$170.8M | -$55.4M |
BHVN has burned cash in almost every quarter: −$473M over the past year, against −$650M the year before.
BHVN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +404K shares |
| 1 year | +48% | +48.7M shares |
| 3 years | +121% | +82.8M shares |
| 5 years | +211% | +103M shares |
| Available history | +188% | +98.6M shares |
BHVN has 151M diluted shares, up 48% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
| Q1 2020 | — |
BHVN Net Leverage
BHVN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
BHVN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 52.6 | Neutral |
| Stochastic | 52.5 | Neutral |
BHVN's weekly RSI is 53 (neutral) and its Stochastic is 52 (neutral).
BHVN PE vs Healthcare Sector
BHVN has no meaningful PE right now: it lost money over the past year.
BHVN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.3 | 5.6% above |
| 20 week MA | $14.1 | 0.2% below |
| 50 week MA | $12.2 | 16% above |
| 100 week MA | $16.8 | 16% below |
| 200 week MA | $24.8 | 43% below |
BHVN's trend is mixed: it's above two of its five weekly moving averages, and 43% below its 200-week average.
BHVN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $7.30 | $13.7 | +88% |
| 2023 | $13.7 | $42.8 | +212% |
| 2024 | $42.8 | $36.7 | -14% |
| 2025 | $36.7 | $11.2 | -70% |
| 2026 YTD | $11.2 | $14.1 | +26% |
BHVN's yearly returns have swung widely, from +212% in 2023 to −70% in 2025. It's up 26% so far in 2026.